OmniAb (OABI) Cash & Equivalents (2021 - 2026)
OmniAb (OABI) reported Cash & Equivalents of $22.9 million for Q1 2026, up 110.62% year-over-year from $10.9 million in Q1 2025, and up 14.25% quarter-over-quarter from $20.1 million in Q4 2025.
OmniAb (OABI) Cash & Equivalents (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Cash & Equivalents data on file, last reported at $22.9 million in Q1 2026.
- Cash & Equivalents for Q1 2026 came in at $22.9 million, up 110.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.9 million (up 110.62% YoY), and the FY2025 annual result was $20.1 million, up 13.99% from the prior year.
- Cash & Equivalents improved to $22.9 million in Q1 2026 per OABI's latest filing, from $20.1 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $33.4 million in Q4 2022 and troughed at $19847.0 in Q3 2022.
- A 5-year average of $17.7 million and a median of $20.1 million in 2025 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2022 and 2023: Cash & Equivalents plunged 94.52% in 2022, then jumped 106943.89% in 2023.
- A 5-year view of Cash & Equivalents shows it stood at $33.4 million in 2022, then slumped by 51.01% to $16.4 million in 2023, then climbed by 7.69% to $17.6 million in 2024, then advanced by 13.99% to $20.1 million in 2025, then advanced by 14.25% to $22.9 million in 2026.
- Business Quant data shows OABI's Cash & Equivalents at $22.9 million in Q1 2026, $20.1 million in Q4 2025, and $28.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 1.91 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.15 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.49 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 558.94 Mn |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | 22.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.94 Mn |
| Dec 31, 2025 | 20.08 Mn |
| Sep 30, 2025 | 28.54 Mn |
| Jun 30, 2025 | 18.28 Mn |
| Mar 31, 2025 | 10.89 Mn |
| Dec 31, 2024 | 17.62 Mn |
| Sep 30, 2024 | 27.24 Mn |
| Jun 30, 2024 | 20.79 Mn |
| Mar 31, 2024 | 19.06 Mn |
| Dec 31, 2023 | 16.36 Mn |
| Sep 30, 2023 | 21.25 Mn |
| Jun 30, 2023 | 20.99 Mn |
| Mar 31, 2023 | 22.91 Mn |
| Dec 31, 2022 | 33.39 Mn |
| Sep 30, 2022 | 19,847.00 |
| Jun 30, 2022 | 159,194.00 |
| Mar 31, 2022 | 434,629.00 |
| Sep 30, 2021 | 362,203.00 |
| Jun 30, 2021 | 36,145.00 |